Edwards Lifesciences (EW) Gross Margin (2009 - 2026)
Edwards Lifesciences' quarterly Gross Margin came in at 78.01% in Q1 2026, down 65.0% year-on-year from 222.87% in Q1 2025, and little changed quarter-over-quarter from 78.15% in Q4 2025.
Edwards Lifesciences has reported Gross Margin for 18 years, with the latest figure at 78.01% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 65.0% year-over-year to 78.01%; the trailing twelve-month figure through Mar 2026 stood at 77.87% (down 163.0% YoY), and the FY2025 full-year result was 78.01%, down 144.0% from the prior year.
- Gross Margin for Q1 2026 stood at 78.01%, roughly flat from 78.15% in the prior quarter.
- The five-year high for Gross Margin was 122.98% in Q4 2022, with the low at 77.52% in Q2 2025.
- Average Gross Margin over 5 years is 81.86%, with a median of 79.85% recorded in 2023.
- Year-over-year, Gross Margin jumped 4626 bps in 2022 and tumbled 4280 bps in 2023.
- Tracing EW's Gross Margin over 5 years: stood at 122.98% in 2022, then sank by 35 bps to 80.18% in 2023, then retreated by 2 bps to 78.91% in 2024, then decreased by 1 bps to 78.15% in 2025, then declined by 0 bps to 78.01% in 2026.
- The last three Gross Margin figures came in at 78.01% (Q1 2026), 78.15% (Q4 2025), and 77.77% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 72.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.01% |
| Dec 31, 2025 | 78.15% |
| Sep 30, 2025 | 77.77% |
| Jun 30, 2025 | 77.52% |
| Mar 31, 2025 | 78.65% |
| Dec 31, 2024 | 78.91% |
| Sep 30, 2024 | 80.59% |
| Jun 30, 2024 | 79.88% |
| Mar 31, 2024 | 78.43% |
| Dec 31, 2023 | 80.18% |
| Sep 30, 2023 | 79.85% |
| Jun 30, 2023 | 80.62% |
| Mar 31, 2023 | 81.25% |
| Dec 31, 2022 | 122.98% |
| Sep 30, 2022 | 80.76% |
| Jun 30, 2022 | 80.39% |
| Mar 31, 2022 | 77.68% |
| Dec 31, 2021 | 76.72% |
| Sep 30, 2021 | 76.21% |
| Jun 30, 2021 | 75.70% |
| Mar 31, 2021 | 75.88% |
| Dec 31, 2020 | 75.14% |
| Sep 30, 2020 | 75.37% |
| Jun 30, 2020 | 74.25% |
| Mar 31, 2020 | 76.51% |
| Dec 31, 2019 | 75.62% |
| Sep 30, 2019 | 73.27% |
| Jun 30, 2019 | 72.03% |
| Mar 31, 2019 | 76.66% |
| Dec 31, 2018 | 75.99% |
| Sep 30, 2018 | 75.19% |
| Jun 30, 2018 | 73.91% |
| Mar 31, 2018 | 73.89% |
| Dec 31, 2017 | 73.52% |
| Sep 30, 2017 | 74.04% |
| Jun 30, 2017 | 74.92% |
| Mar 31, 2017 | 75.60% |
| Dec 31, 2016 | 72.23% |
| Sep 30, 2016 | 72.76% |
| Jun 30, 2016 | 73.33% |
| Mar 31, 2016 | 74.14% |
| Dec 31, 2015 | 73.79% |
| Sep 30, 2015 | 76.17% |
| Jun 30, 2015 | 74.29% |
| Mar 31, 2015 | 76.96% |
| Dec 31, 2014 | 74.05% |
| Sep 30, 2014 | 72.32% |
| Jun 30, 2014 | 73.71% |
| Mar 31, 2014 | 72.07% |
| Dec 31, 2013 | 73.17% |
| Sep 30, 2013 | 74.13% |
| Jun 30, 2013 | 76.10% |
| Mar 31, 2013 | 75.64% |
| Dec 31, 2012 | 75.36% |
| Sep 30, 2012 | 75.06% |
| Jun 30, 2012 | 73.07% |
| Mar 31, 2012 | 72.28% |
| Dec 31, 2011 | 72.20% |
| Sep 30, 2011 | 69.57% |
| Jun 30, 2011 | 70.36% |
| Mar 31, 2011 | 71.12% |
| Dec 31, 2010 | 71.08% |
| Sep 30, 2010 | 72.54% |
| Jun 30, 2010 | 72.51% |
| Mar 31, 2010 | 71.04% |
| Dec 31, 2009 | 70.67% |
| Sep 30, 2009 | 69.76% |
| Jun 30, 2009 | 69.63% |